temozolomide has been researched along with Diffuse Large B-Cell Lymphoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, L | 1 |
| Li, X | 1 |
| He, YZ | 1 |
| Renaud, L | 1 |
| Bossard, JB | 1 |
| Carpentier, B | 1 |
| Terriou, L | 1 |
| Cambier, N | 1 |
| Chanteau, G | 1 |
| Escure, G | 1 |
| Tilmont, R | 1 |
| Barbieux, S | 1 |
| Wemeau, M | 1 |
| Hieulle, J | 1 |
| Boyle, EM | 1 |
| Morschhauser, F | 1 |
| Leshchenko, VV | 1 |
| Kuo, PY | 1 |
| Jiang, Z | 1 |
| Thirukonda, VK | 1 |
| Parekh, S | 1 |
| Cassou-Mounat, T | 1 |
| Delwail, V | 1 |
| Cayssials, E | 1 |
| Terroir, M | 1 |
| Puyade, M | 1 |
| Murawski, N | 1 |
| Pfreundschuh, M | 1 |
| Adachi, J | 1 |
| Mishima, K | 1 |
| Wakiya, K | 1 |
| Suzuki, T | 1 |
| Fukuoka, K | 1 |
| Yanagisawa, T | 1 |
| Matsutani, M | 1 |
| Sasaki, A | 1 |
| Nishikawa, R | 1 |
| Cheung, T | 1 |
| Proulx, A | 1 |
| Fraser, JA | 1 |
| Reni, M | 1 |
| Ferreri, AJ | 1 |
| Landoni, C | 1 |
| Villa, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Trial of Pemetrexed and Temozolomide in Treating Patients With Relapsed PCNSL[NCT01985451] | Phase 2 | 15 participants (Anticipated) | Interventional | 2013-03-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 other studies available for temozolomide and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
[Combination of ibrutinib and temozolomide for the treatment of newly diagnosed elderly primary central nervous system diffuse large B cell lymphoma: a case report].
Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Female; H | 2020 |
Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Ner | 2021 |
Integrative genomic analysis of temozolomide resistance in diffuse large B-cell lymphoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Azacitidine; Cell Line, Tumor; Dacarbazine; Decitabine; | 2014 |
Use of temozolomide instead of cyclophosphamide in diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Dacarbazine; Drug Hypersen | 2016 |
Rituximab maintenance therapy in central nervous system lymphoma?
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Biological Av | 2009 |
O⁶-methylguanine-DNA methyltransferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatment.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Central Nervous System Neoplasms; Dacarb | 2012 |
Primary central nervous system lymphoma presenting as Parinaud syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cranial Irradiation; Dacarbazine; D | 2011 |
Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Humans; Immunocompetence; Lym | 2000 |